1 / 43

Anxiolytics & Hypnotics by Sue Henderson

Anxiolytics & Hypnotics by Sue Henderson. Hypnotic Anxiolytic Anticonvulsant Amnestic Myorelaxant. In what medical circumstances might the amnestic properties of benzodiazepines be useful?. Therapeutic actions. Indications.

makaio
Download Presentation

Anxiolytics & Hypnotics by Sue Henderson

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Anxiolytics & Hypnotics by Sue Henderson

  2. Hypnotic Anxiolytic Anticonvulsant Amnestic Myorelaxant In what medical circumstances might the amnestic properties of benzodiazepines be useful? Therapeutic actions

  3. Indications • Why are benzodiazepines useful in the treatment of alcohol detoxification? • Can they be used in the long term to prevent further alcohol abuse?

  4. Anti-Anxiety Benzodiazepine e.g. Diazepam Non Benzodiazepine e.g. Buspirone Hypnotics: Sedatives Benzodiazepine e.g. Temazepam Non Benzodiazepine e.g. Zopiclone Anti-Anxiety & Hypnotics

  5. Differentiate • What is the difference between an anti-anxiety medication and a hypnotic?

  6. Antidepressants for anxiety

  7. Benzodiazepines • Used mostly in primary care rather than psychiatry. • Often prescribed for problems that are more effectively managed with non-drug therapies. • Temazepam in 10 most frequently prescribed up until 2001.

  8. Benzodiazepines • Should not be 1st line therapy in mental health & sleep management. • Limit use to less than 2 weeks. • Only benefit of continued use is avoiding withdrawal effects (NPS, 1999). • All equally effective but differ in metabolism, speed of onset & half life

  9. 2004-05 National Health Survey • 5% of Australians had used a benzodiazepine for anxiety management in the 2 weeks prior to the survey. • Benzodiazepine use was higher in women and in older age groups (mostly due to sleeping tablets). • Overall use has fallen since 80’s but total use remains high (ABS, 2006).

  10. MCQ Benzodiazepines can safely be prescribed during pregnancy. • A. True • B. False

  11. Dose Equivalents

  12. Short Acting: 3 - 8 hrs • Oxazepam • Temazepam • Triazolam • Buspirone* • Zopiclone*

  13. Intermediate Acting: 10 - 20 hours • Alprazolam • Bromazepam • Clobazam • Clonazepam • Flunitrazepam • Lorazepam • Nitrazepam

  14. Hypnotics • Explain the benefit of using Temazepam over Nitrazepam for assisting with sleep. • Why should hypnotics be used for a limited time to assist with sleep?

  15. Long Acting 1- 3 days: Diazepam X X X

  16. Addiction • Why are short acting benzodiazepines more of a problem with addiction than the long acting ones?

  17. Use of benzodiazepine Even more anxious Reduced anxiety Effect wears off Dependency cycle of benzodiazepines Green, 1996, p. 88

  18. Benzodiazepines: Action • CNS depressant • Enhance the effect of GABA. • GABA is a neurotransmitter that inhibits neuronal activity i.e. reduces the firing rate of neurones.

  19. Agonist = Facilitate • Benzodiazepines bind to a site near the GABA binding site thus facilitating the action of GABA

  20. Death Increasing dose of drug Coma General Anaesthesia Sleep Sedation Disinhibition Relief from anxiety No effect • (Julien, 2001)

  21. Combination CNS depressants

  22. Contra-indications • Myasthenia gravis. • Severe respiratory impairment e.g sleep apnoea, COAD.

  23. Avoid (if possible) • Pregnancy • Lactation

  24. Adverse Effects • Physical dependence occurs in about 1 in 3 patients. • History substance abuse > risk dependence • Increased accident risk. • Tolerance & rebound insomnia. • Alcohol & CNS depressants potentiate adverse effects.

  25. Adverse effects • 60y+ > vulnerability to confusion, memory impairment, over sedation (most common S/E) & falls. • Adverse mood effects: depression, emotional anaesthesia, aggression, increased suicide risk in elderly.

  26. Withdrawal from Benzodiazepines • Abrupt cessation: > seizures • Withdrawal symptoms may occur between doses during continuous use (inter-dose withdrawal). Patients may think these symptoms are due to the original problem. • Withdrawal symptoms: increased anxiety, sleep disorder, aching limbs, nervousness & nausea.

  27. Withdrawal from Benzodiazepines • Withdrawal experienced by 45% of patients discontinuing low dose benzodiazepines & 100% patients on high doses. • Short half life benzodiazepines are associated with more acute & intense withdrawal symptoms. • Long half life benzodiazepines - milder, more delayed withdrawal(NPS, 1999).

  28. Withdrawal from benzodiazepines • Benzodiazepines should not be ceased abruptly. • Dose reduced by 10-20% per week. • Patient allowed to stabilise between each reduction. • Admission for high dose users, history of seizures or psychosis, or for more rapid withdrawal.

  29. Withdrawal from benzodiazepines • Implement relaxation/cognitive techniques. • If necessary referral: • Drug & Alcohol Services • Self Help group TRANX www.tranx.org.au • Psychologist (for CBT)

  30. Overdose Benzodiazepines • Generally safe in overdose unless mixed with alcohol/CNS depressants. • Symptoms overdose: hypotension, respiratory depression & coma. • Treatment: Supportive • Flumazenil rarely indicated

  31. IV Flumazenil • Dangerous to use if mixed overdose (e.g benzodiazepine + tricyclics, amphetamines, other pro-convulsants) - Result in uncontrolled seizure • In dependent individuals severe withdrawal • Flumazenil has a shorter half life ( one hour) than all benzodiazepines Therefore, repeat doses of flumazenil may be required to prevent recurrent symptoms of overdosage once the initial dose of flumazenil wears off.

  32. Flumazenil is a benzodiazepine Antagonist = Blocker Flumazenil binds to GABA receptor displacing benzodizepine

  33. Non benzodiazepines Anxiolytic: Buspirone (Buspar) • Different action to bzd. • Not a CNS depressant. • Partial agonist (stimulant) of dopaminergic & serotoninergic receptors. • No sedation, anti-convulsant or muscle relaxant properties - just anxiolytic. • Delayed action (1-2 weeks) • Effect reduced if benzodiazepine used in last 3/12

  34. Benzodiazepine Rapid onset Can cause sedation May impair performance Additive effects with alcohol May cause dependence & withdrawal Pharmacokinetic change with age Associated with falls in elderly (Keltner & Folks, 2001) Buspirone Delayed onset (cannot be used PRN) Does not cause sedation Does not impair performance No additive effect with alcohol Non addictive No pharmacokinetic change with age Does not cause falls in elderly Expensive (Not on PBS) Comparison of benzodiazepine & buspirone

  35. Presentation: Buspar • White scored • 5 mg & 10 mg tabs

  36. Buspirone: Agonist = Mimic • Buspirone attaches to serotonin receptor mimicking serotonin.

  37. Non benzo Hypnotic: Zopiclone (Imovane) • Similar action, side effects & contraindications to benzo’s.

  38. Benzodiazepines key points • Should not be used in patients with liver disease, history of substance abuse, severe respiratory distress, performing hazardous tasks • Avoid during pregnancy/lactation if possible • Assess for over sedation • Cease slowly • Monitor elderly (cognition, falls) • Be aware they raise seizure threshold, and • Potentiate CNS depressants (alcohol)

  39. Hypnotic key points • Advise re rebound insomnia when medications ceased • Should not be used in sleep apnoea • Avoid alcohol • Hangover effect (impairing performance) • Monitor in elderly (falls, double dosing)

  40. References • Australian Bureau of Statistics. (2006). National health survey 2004-05: Summary of results. Canberra: Australian Bureau of Statistics. • Fortinash, K. M., & Holoday-Worret, P. A. (2000). Psychiatric mental health nursing ( 2nd ed.). St. Louis: Mosby. • Galbraith, A., Bullock, S. & Manias, E. (2001). Fundamentals of pharmacology (3rd ed.). Melbourne: Prentice Hall.

  41. References • Julien, R. M. (2001). A primer of drug action: A concise, non-technical guide to the actions, uses, and side effects of psychoactive drugs. New York: W. H. Freeman and Co. • Keltner, N. L., & Folks, D. G. (2001). Psychotropic drugs (3rd ed.). St. Louis: Mosby. • National Prescribing Service. (1999). Helping patients withdraw. National Prescribing Service Newsletter, No. 4 June. • National Prescribing Service. (1999). Benzodiazepines reviewing long term use: A suggested approach. Prescribing Practice Review, No. 4 July.

More Related